#Coronavirus | Biofortis: providing virological and serological diagnostic tests
Biofortis, a clinical research organisation specialized in nutrition and microbiota analysis, has taken all the necessary steps regarding the health... View Article
GoLiver Therapeutics Receives a Positive Scientific Advice from the European Medicines Agency (EMA)
GoLiver Therapeutics Receives a Positive Scientific Advice from the European Medicines Agency (EMA) on its Clinical Development and Biomanufacturing Strategy... View Article
#Coronavirus | AtlanChim Pharma: special offer on fine Organic chemistry supporting Covid-19 Research
📣 In these extraordinary circumstances ATLANCHIM PHARMA wishes to collaborate with developers of small molecules based COVID-19 #covid #chemistry For your request... View Article
New member | Odaxos
Founded in 2008 in Mayenne (France), Odaxos designs, develops and markets dental devices (dental occlusion). Since 2018, the company... View Article
New member – Vetbiobank
Vetbiobank is a veterinary french biotech specialized since 2011 in the development and manufacturing of innovative animal cell-based drugs for... View Article
Hera-MI launches subsidiary in the United States
Hera-MI announces the creation of its subsidiary in the United States “Hera-MI Corp.” Since November 2019, Hera-MI has been the... View Article
New member | BioExperTeam
Reveals the DNA of your Ambitions BioExperTeam supports Biotech and Pharma Industry leaders to facilitate innovation and business development. Through... View Article
New member | Kalsiom
Targeting calcium signaling to cure auto-immune diseases KALSIOM is a biotech company founded in April 2020 in Brest, France, discovering... View Article
COVID-19 : Cynbiose and VirPath team up in a collaborative R&D project related to the SARS-CoV-2outbreak
Cynbiose in partnership with the academic laboratory VirPath announced today the launch of the COVIBIOSE project. The COVIBIOSE project... View Article
Valneva announces HSR clearance for Lyme vaccine collaboration with Pfizer
Saint-Herblain (France), June 8 2020 – Valneva SE (“Valneva” or “the Company”) announced today that the antitrust-related condition precedent for its Lyme vaccine... View Article